<DOC>
	<DOCNO>NCT01148927</DOCNO>
	<brief_summary>Acute lymphoblastic leukemia ( ALL ) account 20 % adult leukemia . Treatment result adult ALL lag behind improvement achieve pediatric population . A modified version Dana Farber Cancer Institute pediatric protocol use treat adult patient ALL . The result seem superior report adult protocol . However , limited data impact intensified approach result toxicity quality life ( QOL ) survivor . Identifying important factor affect QOL may permit attempt early intervention may help modify regimen mitigate adverse effect QOL . This study evaluate quality life long term survivor adult ALL . It involve patient fill several questionnaire well-validated measure assess various QOL issue concern patient . The following questionnaire use study : - EORTC QLQ C30 ass global health major health domain - Brief Pain Inventory ( BPI ) - Personal Health Questionnaire ( PHQ9 ) ass psychosocial distress - Functional Assessment Cancer Therapy ( FACT ) Fatigue Questionnaire - Peripheral Neuropathy Questionnaire The data obtain questionnaire analyze various domain health quantify .</brief_summary>
	<brief_title>Quality Life Study Adult Patients With Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>previously diagnose adult ALL Tlymphoblastic lymphoma Age &gt; /= 18 Have complete twoyear modify DFCI protocol least three month earlier continuous complete remission Understand English able fill questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>